{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:13:49Z","timestamp":1790201629780,"version":"4.1.0"},"reference-count":20,"publisher":"Ubiquity Press, Ltd.","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":227,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2012.01.002","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T07:01:06Z","timestamp":1332226866000},"page":"361","source":"Crossref","is-referenced-by-count":4,"title":["Trends in Secondary Prevention of Coronary Heart Disease in Tunisia:\n                        Prevention of Recurrences of MI and Stroke"],"prefix":"10.5334","volume":"7","author":[{"given":"N.","family":"Ben Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Lassoued","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Aissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ben Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ben Romdhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"10.1016\/j.gheart.2012.01.002_bib1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/oxfordjournals.pubmed.a024666","article-title":"Prevalence of cardiovascular risk factors in the urban population of Soussa in Tunisia","volume":"19","author":"Ghannem","year":"1997","journal-title":"J\u00a0Pub Health Med"},{"key":"10.1016\/j.gheart.2012.01.002_bib2","series-title":"World health report. Mental health: new understanding, new hope","author":"WHO","year":"2001"},{"key":"10.1016\/j.gheart.2012.01.002_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/01.CIR.104.1.19","article-title":"Trends in acute coronary heart disease mortality, morbidity, medical care from 1985 through 1997: the Minnesota heart survey","volume":"104","author":"McGovern","year":"2001","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.gheart.2012.01.002_bib4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/ije\/30.suppl_1.S17","article-title":"Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987\u20131996","volume":"30","author":"Rosamond","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.gheart.2012.01.002_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0398-7620(04)99094-3","article-title":"Le registre des maladies coronaires en Tunisie: organization et premiers r\u00e9sultats [The first Tunisian cardiovascular diseases register: processes and results]","volume":"52","author":"Ben Romdhane","year":"2004","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.gheart.2012.01.002_bib6","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinte.162.21.2405","article-title":"The underlying risk of death after myocardial infarction in the absence of treatment","volume":"162","author":"Law","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gheart.2012.01.002_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10654-006-9087-9","article-title":"Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy","volume":"22","author":"Gouya","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.gheart.2012.01.002_bib8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A\u00a0strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.gheart.2012.01.002_bib9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(09)60330-5","article-title":"Cardiovascular prevention guidelines in daily practice. a comparison of EUROASPIRE I, II, and III surveys in eight European countries","volume":"373","author":"Kotseva","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gheart.2012.01.002_bib10","first-page":"820","article-title":"WHO study on Prevention of REcurrences of Myocardial infarction and StrokE [WHO-PREMISE]","volume":"83","author":"Mendis","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.gheart.2012.01.002_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/heart.88.2.159","article-title":"Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey","volume":"88","author":"Danchin","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.gheart.2012.01.002_bib12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archinte.159.6.561","article-title":"Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?","volume":"159","author":"McCormick","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gheart.2012.01.002_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"Engl J Med"},{"key":"10.1016\/j.gheart.2012.01.002_bib14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0300-8932(02)76708-0","article-title":"Nuevos datos sobre la prevenci\u00f3n secundaria del infarto de miocardio en Espa\u00f1a. Resultados del estudio PREVESE II. [New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II Study]","volume":"55","author":"De Velasco","year":"2002","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.gheart.2012.01.002_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.gheart.2012.01.002_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.hjr.0000244573.10229.6e","article-title":"Use of secondary preventive medications after the first attack of acute coronary syndrome","volume":"14","author":"Salomaa","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.gheart.2012.01.002_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4065\/84.8.741","article-title":"Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach","volume":"84","author":"O'Keefe","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gheart.2012.01.002_bib18","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2012.01.002_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/heart.88.1.15","article-title":"Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?","volume":"88","author":"Reid","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.gheart.2012.01.002_bib20","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1053\/euhj.1999.1631","article-title":"Increasing the impact of cardiological treatments: how best to reduce deaths","volume":"20","author":"Capewell","year":"1999","journal-title":"Eur Heart J"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816012000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816012000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2012.01.002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:47:32Z","timestamp":1657543652000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2012.01.002\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2012.01.002","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}